JPMorgan analyst Ken Goldman lowered the firm’s price target on Mondelez to $81 from $82 and keeps an Overweight rating on the shares ahead of the Q4 report. The analyst reduced our out-year earnings estimates slightly, partly to account for a greater currency headwind.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDLZ:
- GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits
- POST, MDLZ, CELH: Which Strong-Buy-Rated Stock is Best?
- Mondelēz International to Report Q4 and Full Year 2023 Financial Results on Jan 30, 2024
- Mondelez price target raised to $80 from $79 at Barclays
- Mondelez price target raised to $78 from $74 at Morgan Stanley
